QTc prolongation after regadenoson administration
Authors:
- 1 October 2012
- journal article
- case report
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 19 (5) , 1080-1082
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious DogsJournal of Cardiovascular Pharmacology, 2008
- Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion ImagingJACC: Cardiovascular Imaging, 2008
- Initial Clinical Experience With Regadenoson, a Novel Selective A2AAgonist for Pharmacologic Stress Single-Photon Emission Computed Tomography Myocardial Perfusion ImagingJACC, 2005
- QT interval in right and left bundle-branch block.Heart, 1973